SCPH - scPharmaceuticals Inc.
About scPharmaceuticals Inc. (https://www.scpharmaceuticals.com)
scPharmaceuticals Inc. is a pharmaceutical firm dedicated to developing and commercializing a variety of medicinal products. Its primary investigational therapy, FUROSCIX, is a specialized formulation of furosemide delivered through an on-body infusor, intended for managing congestion in heart failure patients. The company's pipeline also encompasses scCeftriaxone, an antibiotic aimed at treating infections caused by both gram-positive and gram-negative bacteria, as well as the scCarbapenem program, another antibiotic designed for gram-negative bacterial infections. Additionally, scPharmaceuticals has entered into a collaboration agreement with West Pharmaceutical Services, Inc. for the advancement of a single-use SmartDose device. Founded in 2013, the company's main operations are based in Burlington, Massachusetts.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| John H. Tucker | President, Chief Executive Officer, Principal Executive Officer & Director | 1963 | $1,054,130 USD |
| Rachael Nokes | Chief Financial Officer | 1976 | $632,154 USD |
| John Mohr | Senior Vice President of Clinical Development & Medical Affairs | – | – |
| Katherine Taudvin | Vice President of Corporate Affairs & Human Resources | – | – |
| Michael D. Hassman | Senior Vice President of Technical Operations | – | – |
| Steve Parsons | Senior Vice President of Commercial | – | – |